Shanghai Tianwei Biology Pharmacy

Shanghai Tianwei Biological Pharmaceutical Co., Ltd., established in 2001, is a specialized pharmaceutical company focused on the development and manufacture of high-end Active Pharmaceutical Ingredients (APIs) and finished dosage forms. As a subsidiary of Shanghai Modern Pharmaceutical (part of the Sinopharm Group), the company has established itself as a leader in the production of immunosuppressants, including Tacrolimus, Sirolimus, and Everolimus. Its portfolio also features advanced antifungal agents such as Caspofungin and Micafungin, produced through sophisticated fermentation and synthesis processes. Tianwei operates state-of-the-art manufacturing facilities that comply with international GMP standards, supplying critical medications to global markets across Asia, Europe, and the Americas.